Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. (DRMA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · DRMA · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Dermata Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
DRMA insider buying and selling by quarter
DRMA insider selling · DRMA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · DRMA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
DRMA executive sell shares · DRMA board member insider trading · DRMA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 17, 2026 | Bedoya-Toro Munera Maria E SVP, Regulatory Affairs | Purchase | 1,000 | $1K | Form 4 |
| Dec 23, 2025 | Van Hoose Kyri K. SVP, CFO | Award | 122,549 | — | Form 4 |
| Dec 23, 2025 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO · Director | Award | 490,196 | — | Form 4 |
| Dec 23, 2025 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO · Director | Award | 122,549 | — | Form 4 |
| Jan 21, 2025 | FISHER MARY Director | Award | 196,851 | — | Form 4 |
| Jan 21, 2025 | Van Hoose Kyri K. SVP, CFO | Award | 78,741 | — | Form 4 |
| Jan 21, 2025 | PROEHL GERALD T President, CEO and Chairman · Director | Award | 787,402 | — | Form 4 |
| Jan 23, 2025 | HALE DAVID F Director | Award | 78,741 | — | Form 4 |
| Oct 6, 2022 | Sandler Andrew Seth Director | Award | 10,120 | — | Form 4 |
| Oct 6, 2022 | Bradrick Brittany Director | Award | 9,810 | — | Form 4 |
| Oct 6, 2022 | HALE DAVID F Director | Award | 30,155 | — | Form 4 |
| Oct 6, 2022 | FISHER MARY Director | Award | 9,810 | — | Form 4 |
| Oct 6, 2022 | Scott Kathleen D. Director | Award | 11,359 | — | Form 4 |
| Oct 6, 2022 | WIERENGA WENDELL Director | Award | 20,654 | — | Form 4 |
| Jul 7, 2022 | HALE DAVID F Director | Award | 26,441 | — | Form 4 |
| Jul 7, 2022 | Scott Kathleen D. Director | Award | 9,960 | — | Form 4 |
| Jul 7, 2022 | WIERENGA WENDELL Director | Award | 18,110 | — | Form 4 |
| Jul 7, 2022 | FISHER MARY Director | Award | 8,602 | — | Form 4 |
| Apr 7, 2022 | WIERENGA WENDELL Director | Award | 10,593 | — | Form 4 |
| Apr 7, 2022 | FISHER MARY Director | Award | 5,031 | — | Form 4 |
| Apr 7, 2022 | Scott Kathleen D. Director | Award | 5,826 | — | Form 4 |
| Apr 7, 2022 | HALE DAVID F Director | Award | 15,466 | — | Form 4 |
| Nov 23, 2021 | PROEHL GERALD T President, CEO and Chairman · Director | Purchase | 20,000 | $48K | Form 4 |
| Aug 17, 2021 | Bedoya-Toro Munera Maria E SVP | Other | 13,658 | — | Form 4 |
| Aug 17, 2021 | Bedoya-Toro Munera Maria E SVP | Other | 17,421 | — | Form 4 |
Bedoya-Toro Munera Maria E
SVP, Regulatory Affairs
Date
Feb 17
Shares
1,000
Price
$1.27
Value
$1K
PROEHL GERALD T
PRESIDENT, CHAIRMAN, CEO · Director
Date
Dec 23
Shares
490,196
Price
—
Value
—
PROEHL GERALD T
PRESIDENT, CHAIRMAN, CEO · Director
Date
Dec 23
Shares
122,549
Price
—
Value
—
PROEHL GERALD T
President, CEO and Chairman · Director
Date
Jan 21
Shares
787,402
Price
—
Value
—
PROEHL GERALD T
President, CEO and Chairman · Director
Date
Nov 23
Shares
20,000
Price
$2.40
Value
$48K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About DRMA insider trading
DRMA insider trades
Dermata Therapeutics, Inc. (DRMA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PROEHL GERALD T (PRESIDENT, CHAIRMAN, CEO · Director), Bedoya-Toro Munera Maria E (SVP, Regulatory Affairs), Van Hoose Kyri K. (SVP, CFO). Over the past 12 months, 3 insiders have filed transactions with the SEC. DRMA insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Dermata Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
DRMA insider trading · 5 questionsThe insiders of Dermata Therapeutics, Inc. (DRMA) include executives and directors such as PROEHL GERALD T (PRESIDENT, CHAIRMAN, CEO · Director), Bedoya-Toro Munera Maria E (SVP, Regulatory Affairs), Van Hoose Kyri K. (SVP, CFO), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026